What is a stock summary page? Click here for an overview.
Business Description
Aardvark Therapeutics Inc
NAICS : 541715
SIC : 2833
Description
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 94.56 | |||||
| Equity-to-Asset | -0.71 | |||||
| Debt-to-Equity | -0.01 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.32 | |||||
| 9-Day RSI | 48.97 | |||||
| 14-Day RSI | 45.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.05 | |||||
| Quick Ratio | 15.05 | |||||
| Cash Ratio | 14.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.25 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -20.02 | |||||
| ROIC % | -709.4 | |||||
| ROC (Joel Greenblatt) % | -3167.97 | |||||
| ROCE % | -23.51 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -6.82 | |||||
| EV-to-EBITDA | -6.86 | |||||
| EV-to-FCF | -8.49 | |||||
| Earnings Yield (Greenblatt) % | -14.66 | |||||
| FCF Yield % | -6.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AARD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aardvark Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.607 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 45.56 | ||
| 14-Day ATR ($) | 1.138154 | ||
| 20-Day SMA ($) | 7.8255 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 4.88 - 19.58 | ||
| Shares Outstanding (Mil) | 21.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aardvark Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aardvark Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aardvark Therapeutics Inc Frequently Asked Questions
What is Aardvark Therapeutics Inc(AARD)'s stock price today?
The current price of AARD is $7.93. The 52 week high of AARD is $19.58 and 52 week low is $4.88.
When is next earnings date of Aardvark Therapeutics Inc(AARD)?
The next earnings date of Aardvark Therapeutics Inc(AARD) is 2025-05-30 Est..
Does Aardvark Therapeutics Inc(AARD) pay dividends? If so, how much?
Aardvark Therapeutics Inc(AARD) does not pay dividend.
Guru Commentaries on NAS:AARD
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers